Inventor
SKWIERCZYNSKI RAYMOND D
US20 patents
⚠️ This page may combine multiple inventors who share the name “SKWIERCZYNSKI RAYMOND D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MILLENNIUM PHARM INC
8 patentsUS8859504B2Oct 14, 2014
Boronate ester compounds and pharmaceutical compositions thereof
MILLENNIUM PHARM INC29 citations94
US9175018B2Nov 3, 2015
Boronate ester compounds and pharmaceutical compositions thereof
MILLENNIUM PHARM INC12 citations90
US9175017B2Nov 3, 2015
Boronate ester compounds and pharmaceutical compositions thereof
MILLENNIUM PHARM INC5 citations82
US11485746B2Nov 1, 2022
Boronate ester compounds and pharmaceutical compositions thereof
MILLENNIUM PHARM INC2 citations71
US10604538B2Mar 31, 2020
Boronate ester compounds and pharmaceutical compositions thereof
MILLENNIUM PHARM INC2 citations71
US10526351B2Jan 7, 2020
Boronate ester compounds and pharmaceutical compositions thereof
MILLENNIUM PHARM INC2 citations71
US9504693B2Nov 29, 2016
Pharmaceutical compositions for the treatment of cancer and other diseases or disorders
MILLENNIUM PHARM INC3 citations66
US9127011B2Sep 8, 2015
Pharmaceutical compositions for the treatment of cancer and other diseases or disorders
MILLENNIUM PHARM INC4 citations66
TREMEAU PHARMACEUTICALS INC
6 patentsUS10987337B2Apr 27, 2021
Purified forms of rofecoxib, methods of manufacture and use
TREMEAU PHARMACEUTICALS INC9 citations83
US10945992B1Mar 16, 2021
Dosage forms of rofecoxib and related methods
TREMEAU PHARMACEUTICALS INC6 citations78
US11617735B2Apr 4, 2023
Purified forms of rofecoxib, methods of manufacture and use
TREMEAU PHARMACEUTICALS INC2 citations70
US11576890B2Feb 14, 2023
Purified forms of rofecoxib, methods of manufacture and use
TREMEAU PHARMACEUTICALS INC2 citations70
US11559509B2Jan 24, 2023
Purified forms of rofecoxib, methods of manufacture and use
TREMEAU PHARMACEUTICALS INC2 citations70
US11872206B2Jan 16, 2024
Purified forms of rofecoxib, methods of manufacture and use
TREMEAU PHARMACEUTICALS INC0 citations59
3M INNOVATIVE PROPERTIES CO
4 patentsUS6245776B1Jun 12, 2001
Formulations and methods for treatment of mucosal associated conditions with an immune response modifier
3M INNOVATIVE PROPERTIES CO456 citations98
US6486168B1Nov 26, 2002
Formulations and methods for treatment of mucosal associated conditions with an immune response modifier
3M INNOVATIVE PROPERTIES CO217 citations97
US7968562B2Jun 28, 2011
Pharmaceutical formulations comprising an immune response modifier
3M INNOVATIVE PROPERTIES CO43 citations89
US10071156B2Sep 11, 2018
Aqueous gel formulations containing immune response modifiers
3M INNOVATIVE PROPERTIES CO0 citations45